ATHE - Alterity Therapeutics Ltd - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATHE is currently covered by 1 analysts with an average price target of $10.41. This is a potential upside of $7.1 (214.5%) from yesterday's end of day stock price of $3.31.

Alterity Therapeutics Ltd's activity chart (see below) currently has 2 price targets and 3 ratings on display. The stock rating distribution of ATHE is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ATHE is $3, Lowest price target is $3, average price target is $10.41.

Most recent stock forecast was given by AYDIN HUSEYNOV from LADENBURG on 05-Jun-2023. First documented stock forecast 20-Aug-2021.

Best performing analysts who are covering ATHE - Alterity Therapeutics Ltd:

Aydin Huseynov

Currently out of the existing stock ratings of ATHE, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$6.66 (199.40%)

$20

1 years 7 months 9 days ago
(05-Jun-2023)

0/3 (0%)

$7.1 (244.83%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATHE (Alterity Therapeutics Ltd) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ATHE (Alterity Therapeutics Ltd) with a proven track record?

AYDIN HUSEYNOV

Which analyst has the most public recommendations on ATHE (Alterity Therapeutics Ltd)?

Aydin Huseynov works at LADENBURG and has 1 price targets and 2 ratings on ATHE

Which analyst is the currently most bullish on ATHE (Alterity Therapeutics Ltd)?

Aydin Huseynov with highest potential upside - $6.66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?